EMERGENT BIOSOLUTIONS INC. Defined Benefit Plan, Funded (Unfunded) Status of Plan
EMERGENT BIOSOLUTIONS INC. (EBS) had Defined Benefit Plan, Funded (Unfunded) Status of Plan of -$7.90 million as of 2022-12-31, per its 10-K filed 2024-03-08.
Discontinued › Notes › Compensation Related Costs › Retirement Benefits › Defined Benefit Plan › Defined Benefit Plan, Funded (Unfunded) Status of Plan
us-gaap:DefinedBenefitPlanFundedStatusOfPlan · last filed 2024-03-08
- 2022-12-31: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$7.90M.
- 2021-12-31: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$17.50M.
- 2020-12-31: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$21.60M.
- 2019-12-31: Defined Benefit Plan, Funded (Unfunded) Status of Plan -$14.60M; Defined Benefit Plan, Funded (Unfunded) Status of Plan as first filed -$14.70M.
| Period end | Defined Benefit Plan, Funded (Unfunded) Status of Plan | Defined Benefit Plan, Funded (Unfunded) Status of Plan as first filed |
|---|---|---|
| 2022-12-31 | -$7.90M 10-K · filed 2024-03-08 | |
| 2021-12-31 | -$17.50M 10-K/A · filed 2023-12-11 | |
| 2020-12-31 | -$21.60M 10-K · filed 2022-02-25 | |
| 2019-12-31 | -$14.60M 10-K · filed 2021-02-19 | -$14.70M 10-K · filed 2020-02-25 |
| 2018-12-31 | -$10.40M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |